These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 13191624)

  • 1. Triethylenemelamine and its associations in the treatment of hemolymphoblastoses and other neoplasms.
    MARMONT A; FUSCO F
    G Ital Chemioter; 1954; 1(1):193-5. PubMed ID: 13191624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of TEM on chronic leukemia, lymphogranulomatosis and lymphosarcoma].
    HAEHNER E; HEINEN W; LOOSEN H; SCHMIDT H
    Med Klin; 1954 May; 49(21):853-4; passim. PubMed ID: 13164965
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of lymphomatous diseases with triethylene melamine.
    MEYER LM; SCHWARTZ SO; SAWITSKY A; BEYERS MR; RITZ ND; BRAHIN C; DIEFENBACH W; KLEINSCHMIDT W; FRIEDMAN I
    Acta Med Scand Suppl; 1952; 272():1-36. PubMed ID: 13039963
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hemoblastosis with triethylene melamine].
    LINKE A; LASCH HG
    Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trials with triethylene melamine].
    FERRARI M; KASDORF H
    Arch Urug Med Cir Espec; 1953; 42(3-4):134-44. PubMed ID: 14350952
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immediate results of triethylene melamine therapy of neoplastic diseases].
    LENTI G; GAVOSTO F
    Minerva Med; 1953 Jan; 44(1-2):1-19. PubMed ID: 13054386
    [No Abstract]   [Full Text] [Related]  

  • 7. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease.
    HAMBLY CK; ROBERTSON TI
    Med J Aust; 1955 Jun; 42(1 25):900-11. PubMed ID: 13243982
    [No Abstract]   [Full Text] [Related]  

  • 8. TRIETHYLENE-MELAMINE.
    Br Med J; 1955 Jun; 1(4926):1380-1. PubMed ID: 14363905
    [No Abstract]   [Full Text] [Related]  

  • 9. [Early resistance to triethylene melamine].
    LATTANZI A; PARDELLI G
    Riforma Med; 1954 Jan; 68(1):7-12. PubMed ID: 13156339
    [No Abstract]   [Full Text] [Related]  

  • 10. [Association of intralymphatic radiotherapy and alkylating agents in the treatment of retroperitoneal hematosarcomas].
    Bonadonna G; Chiappa S; Di Pietro S; Marano O; Molinari R; Uslenghi C
    Nouv Rev Fr Hematol; 1967; 7(3):381-92. PubMed ID: 4229322
    [No Abstract]   [Full Text] [Related]  

  • 11. Results in the use of triethylene melamine (TEM) in malignant lymphomas and chronic leukemias.
    MEZA ARRAU C; NIJAMKIN A
    Rev Med Chil; 1955 Feb; 83(2):90-5. PubMed ID: 14385308
    [No Abstract]   [Full Text] [Related]  

  • 12. [Triethylene melamine treatment of leukemia and lymphogranulomatosis].
    CAKMAKCI A
    Turk Tip Cemiy Mecm; 1954 Jun; 20(6):290-314. PubMed ID: 13217043
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of malignant diseases with triethylene melamine].
    ROMEO ORBEGOZO JM
    Rev Clin Esp; 1953 Sep; 50(5):382-6. PubMed ID: 13134813
    [No Abstract]   [Full Text] [Related]  

  • 14. [Triethylene melamine therapy of leukemia and lymphogranulomatosis].
    MILIC N
    Lijec Vjesn; 1954; 76(1-2):40-6. PubMed ID: 13175578
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with triethylene melamine in therapy of neoplastic diseases of the blood].
    BOCK HE; KIRBERGER E; WOELFFER U
    Z Klin Med; 1953; 150(5):482-98. PubMed ID: 13137291
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and hematologic effects of triethylene melamine.
    AXELROD AR; BERMAN L; MURPHY RV
    Am J Med; 1953 Nov; 15(5):684-94. PubMed ID: 13104437
    [No Abstract]   [Full Text] [Related]  

  • 17. [Practical results of use of triethylenemelamine in neoplastic diseases. III. Lymphosarcoma and reticulosarcoma].
    LENTI G; GAVOSTO F
    G Ital Chemioter; 1954; 1(1):103-4. PubMed ID: 13191594
    [No Abstract]   [Full Text] [Related]  

  • 18. [Massive doses of cortisone in the treatment of malignant diseases of the hemopoietic system].
    PHOCAS E; BENOS S; PAVLATOS F; PAPASTELIATOS N
    Rev Med Moyen Orient; 1962; 19():65-72. PubMed ID: 14038343
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia].
    NEUMANN C
    Klin Wochenschr; 1952 Dec; 30(47-48):1105-8. PubMed ID: 13023980
    [No Abstract]   [Full Text] [Related]  

  • 20. [Practical results of use of triethylenemelamine in neoplastic diseases. I. Hodgkin's disease].
    LENTI G; GAVOSTO F
    G Ital Chemioter; 1954; 1(1):101-2. PubMed ID: 13191592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.